Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumors.

Lockhart AC, Calvo E, Tolcher AW, Rowinsky EK, Shackleton G, Morrison JG, Rafi R, VerMeulen W, Rothenberg ML.

Am J Clin Oncol. 2009 Feb;32(1):9-14. doi: 10.1097/COC.0b013e318178331b.

PMID:
19194116
2.

Phase I dose-escalation study of the thioxanthone SR271425 administered intravenously once every 3 weeks in patients with advanced malignancies.

Goncalves PH, High F, Juniewicz P, Shackleton G, Li J, Boerner S, LoRusso PM.

Invest New Drugs. 2008 Aug;26(4):347-54. doi: 10.1007/s10637-008-9135-2. Epub 2008 May 1.

3.

High-performance liquid chromatographic method for the estimation of the novel investigational anti-cancer agent SR271425 and its metabolites in mouse plasma.

Poondru S, Zhou S, Rake J, Shackleton G, Corbett TH, Parchment RE, Jasti BR.

J Chromatogr B Biomed Sci Appl. 2001 Aug 5;759(1):175-8.

PMID:
11499623
4.

A survey of health agencies' responses to non-English-speaking women's health needs in south Australia.

Dolman J, Shackleton G, Ziaian T, Gay J, Yeboah DA.

Aust N Z J Public Health. 1996 Apr;20(2):155-60.

PMID:
8799090
5.

Diverse mechanisms of calcium mobilization by peroxisome proliferators in rat hepatocytes.

Shackleton GL, Gibson GG, Sharma RK, Howes D, Orrenius S, Kass GE.

Toxicol Appl Pharmacol. 1995 Feb;130(2):294-303.

PMID:
7871541
6.

Antioxidant defenses in the bile duct-ligated rat.

Singh S, Shackleton G, Ah-Sing E, Chakraborty J, Bailey ME.

Gastroenterology. 1992 Nov;103(5):1625-9.

PMID:
1426883
7.

Supplemental Content

Loading ...
Support Center